Device Week, 14 May — AdvaMed Conference And Innovative Brain Monitoring Technology
In this edition of Device Week, Medtech Insight’s Marion Webb reviews some informative sessions at the AdvaMed Medtech Conference last week, panels on the emergence of medtech in consumer tech. Reporter Barnaby Pickering talks about Cumulus Neuroscience and its innovative work in clinical- trial monitoring.
You may also be interested in...
As Exo awaits FDA clearance for its handheld ultrasound device, it will use the new funding for planned commercialization. Exo has raised more than $320m to date.
The UK-based company said it will use the new funding to advance commercialization of its daytime treatment for mild sleep apnea and snoring.
Babson recently raised $31m to accelerate commercialization of its blood testing “ecosystem,” developed with help from Siemens Healthineers and Becton Dickinson.